Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin and Beidougen capsule in type 2 diabetes mellitus
NCT05667220Phase 4Unknown
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Dec 2022
- Primary completion
- Oct 2023
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of beidougen in type 2 diabetes mellitus (T2DM), sponsored by Beijing Chaoyang Hospital. Status: unknown.
02
Drugs
beidougen
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05667220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05667220.